Inactivated Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type ( Viral Vaccine, Bacterial Vaccine ); Method ( Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, Others ); Route of Administration ( Oral, Subcutaneous, Intravenous, Others )
Report Code: TIPRE00010958 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Inactivated Vaccines Market - By Type
1.3.2 Inactivated Vaccines Market - By Method
1.3.3 Inactivated Vaccines Market - By Route of Administration
1.3.4 Inactivated Vaccines Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INACTIVATED VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INACTIVATED VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INACTIVATED VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. INACTIVATED VACCINES - GLOBAL MARKET OVERVIEW
6.2. INACTIVATED VACCINES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INACTIVATED VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. VIRAL VACCINE
7.3.1. Overview
7.3.2. Viral Vaccine Market Forecast and Analysis
7.4. BACTERIAL VACCINE
7.4.1. Overview
7.4.2. Bacterial Vaccine Market Forecast and Analysis
8. INACTIVATED VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - METHOD
8.1. OVERVIEW
8.2. METHOD MARKET FORECASTS AND ANALYSIS
8.3. SOLVENT DETERGENT METHOD
8.3.1. Overview
8.3.2. Solvent Detergent Method Market Forecast and Analysis
8.4. RADIATION METHOD
8.4.1. Overview
8.4.2. Radiation Method Market Forecast and Analysis
8.5. PH CONCENTRATION
8.5.1. Overview
8.5.2. pH Concentration Market Forecast and Analysis
8.6. HEAT INACTIVATION
8.6.1. Overview
8.6.2. Heat Inactivation Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. INACTIVATED VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. SUBCUTANEOUS
9.4.1. Overview
9.4.2. Subcutaneous Market Forecast and Analysis
9.5. INTRAVENOUS
9.5.1. Overview
9.5.2. Intravenous Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. INACTIVATED VACCINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Inactivated Vaccines Market Overview
10.1.2 North America Inactivated Vaccines Market Forecasts and Analysis
10.1.3 North America Inactivated Vaccines Market Forecasts and Analysis - By Type
10.1.4 North America Inactivated Vaccines Market Forecasts and Analysis - By Method
10.1.5 North America Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.1.6 North America Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Inactivated Vaccines Market
10.1.6.1.1 United States Inactivated Vaccines Market by Type
10.1.6.1.2 United States Inactivated Vaccines Market by Method
10.1.6.1.3 United States Inactivated Vaccines Market by Route of Administration
10.1.6.2 Canada Inactivated Vaccines Market
10.1.6.2.1 Canada Inactivated Vaccines Market by Type
10.1.6.2.2 Canada Inactivated Vaccines Market by Method
10.1.6.2.3 Canada Inactivated Vaccines Market by Route of Administration
10.1.6.3 Mexico Inactivated Vaccines Market
10.1.6.3.1 Mexico Inactivated Vaccines Market by Type
10.1.6.3.2 Mexico Inactivated Vaccines Market by Method
10.1.6.3.3 Mexico Inactivated Vaccines Market by Route of Administration
10.2. EUROPE
10.2.1 Europe Inactivated Vaccines Market Overview
10.2.2 Europe Inactivated Vaccines Market Forecasts and Analysis
10.2.3 Europe Inactivated Vaccines Market Forecasts and Analysis - By Type
10.2.4 Europe Inactivated Vaccines Market Forecasts and Analysis - By Method
10.2.5 Europe Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.2.6 Europe Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Inactivated Vaccines Market
10.2.6.1.1 Germany Inactivated Vaccines Market by Type
10.2.6.1.2 Germany Inactivated Vaccines Market by Method
10.2.6.1.3 Germany Inactivated Vaccines Market by Route of Administration
10.2.6.2 France Inactivated Vaccines Market
10.2.6.2.1 France Inactivated Vaccines Market by Type
10.2.6.2.2 France Inactivated Vaccines Market by Method
10.2.6.2.3 France Inactivated Vaccines Market by Route of Administration
10.2.6.3 Italy Inactivated Vaccines Market
10.2.6.3.1 Italy Inactivated Vaccines Market by Type
10.2.6.3.2 Italy Inactivated Vaccines Market by Method
10.2.6.3.3 Italy Inactivated Vaccines Market by Route of Administration
10.2.6.4 Spain Inactivated Vaccines Market
10.2.6.4.1 Spain Inactivated Vaccines Market by Type
10.2.6.4.2 Spain Inactivated Vaccines Market by Method
10.2.6.4.3 Spain Inactivated Vaccines Market by Route of Administration
10.2.6.5 United Kingdom Inactivated Vaccines Market
10.2.6.5.1 United Kingdom Inactivated Vaccines Market by Type
10.2.6.5.2 United Kingdom Inactivated Vaccines Market by Method
10.2.6.5.3 United Kingdom Inactivated Vaccines Market by Route of Administration
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Inactivated Vaccines Market Overview
10.3.2 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis - By Method
10.3.5 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.3.6 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Inactivated Vaccines Market
10.3.6.1.1 Australia Inactivated Vaccines Market by Type
10.3.6.1.2 Australia Inactivated Vaccines Market by Method
10.3.6.1.3 Australia Inactivated Vaccines Market by Route of Administration
10.3.6.2 China Inactivated Vaccines Market
10.3.6.2.1 China Inactivated Vaccines Market by Type
10.3.6.2.2 China Inactivated Vaccines Market by Method
10.3.6.2.3 China Inactivated Vaccines Market by Route of Administration
10.3.6.3 India Inactivated Vaccines Market
10.3.6.3.1 India Inactivated Vaccines Market by Type
10.3.6.3.2 India Inactivated Vaccines Market by Method
10.3.6.3.3 India Inactivated Vaccines Market by Route of Administration
10.3.6.4 Japan Inactivated Vaccines Market
10.3.6.4.1 Japan Inactivated Vaccines Market by Type
10.3.6.4.2 Japan Inactivated Vaccines Market by Method
10.3.6.4.3 Japan Inactivated Vaccines Market by Route of Administration
10.3.6.5 South Korea Inactivated Vaccines Market
10.3.6.5.1 South Korea Inactivated Vaccines Market by Type
10.3.6.5.2 South Korea Inactivated Vaccines Market by Method
10.3.6.5.3 South Korea Inactivated Vaccines Market by Route of Administration
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Inactivated Vaccines Market Overview
10.4.2 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis - By Method
10.4.5 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.4.6 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Inactivated Vaccines Market
10.4.6.1.1 South Africa Inactivated Vaccines Market by Type
10.4.6.1.2 South Africa Inactivated Vaccines Market by Method
10.4.6.1.3 South Africa Inactivated Vaccines Market by Route of Administration
10.4.6.2 Saudi Arabia Inactivated Vaccines Market
10.4.6.2.1 Saudi Arabia Inactivated Vaccines Market by Type
10.4.6.2.2 Saudi Arabia Inactivated Vaccines Market by Method
10.4.6.2.3 Saudi Arabia Inactivated Vaccines Market by Route of Administration
10.4.6.3 U.A.E Inactivated Vaccines Market
10.4.6.3.1 U.A.E Inactivated Vaccines Market by Type
10.4.6.3.2 U.A.E Inactivated Vaccines Market by Method
10.4.6.3.3 U.A.E Inactivated Vaccines Market by Route of Administration
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Inactivated Vaccines Market Overview
10.5.2 South and Central America Inactivated Vaccines Market Forecasts and Analysis
10.5.3 South and Central America Inactivated Vaccines Market Forecasts and Analysis - By Type
10.5.4 South and Central America Inactivated Vaccines Market Forecasts and Analysis - By Method
10.5.5 South and Central America Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.5.6 South and Central America Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Inactivated Vaccines Market
10.5.6.1.1 Brazil Inactivated Vaccines Market by Type
10.5.6.1.2 Brazil Inactivated Vaccines Market by Method
10.5.6.1.3 Brazil Inactivated Vaccines Market by Route of Administration
10.5.6.2 Argentina Inactivated Vaccines Market
10.5.6.2.1 Argentina Inactivated Vaccines Market by Type
10.5.6.2.2 Argentina Inactivated Vaccines Market by Method
10.5.6.2.3 Argentina Inactivated Vaccines Market by Route of Administration
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INACTIVATED VACCINES MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. INACTIVATED VACCINES MARKET, KEY COMPANY PROFILES
13.1. BHARAT BIOTECH
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CSL LTD.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. EMERGENT BIOSOLUTIONS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GLAXOSMITHKLINE PLC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MERCK AND CO., INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NOVARTIS AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PFIZER INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SANOFI
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SEQIRUS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. VALNEVA SE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Inactivated Vaccines Market - By Type
1.3.2 Inactivated Vaccines Market - By Method
1.3.3 Inactivated Vaccines Market - By Route of Administration
1.3.4 Inactivated Vaccines Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INACTIVATED VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INACTIVATED VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INACTIVATED VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. INACTIVATED VACCINES - GLOBAL MARKET OVERVIEW
6.2. INACTIVATED VACCINES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INACTIVATED VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. VIRAL VACCINE
7.3.1. Overview
7.3.2. Viral Vaccine Market Forecast and Analysis
7.4. BACTERIAL VACCINE
7.4.1. Overview
7.4.2. Bacterial Vaccine Market Forecast and Analysis
8. INACTIVATED VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - METHOD
8.1. OVERVIEW
8.2. METHOD MARKET FORECASTS AND ANALYSIS
8.3. SOLVENT DETERGENT METHOD
8.3.1. Overview
8.3.2. Solvent Detergent Method Market Forecast and Analysis
8.4. RADIATION METHOD
8.4.1. Overview
8.4.2. Radiation Method Market Forecast and Analysis
8.5. PH CONCENTRATION
8.5.1. Overview
8.5.2. pH Concentration Market Forecast and Analysis
8.6. HEAT INACTIVATION
8.6.1. Overview
8.6.2. Heat Inactivation Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. INACTIVATED VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. SUBCUTANEOUS
9.4.1. Overview
9.4.2. Subcutaneous Market Forecast and Analysis
9.5. INTRAVENOUS
9.5.1. Overview
9.5.2. Intravenous Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. INACTIVATED VACCINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Inactivated Vaccines Market Overview
10.1.2 North America Inactivated Vaccines Market Forecasts and Analysis
10.1.3 North America Inactivated Vaccines Market Forecasts and Analysis - By Type
10.1.4 North America Inactivated Vaccines Market Forecasts and Analysis - By Method
10.1.5 North America Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.1.6 North America Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Inactivated Vaccines Market
10.1.6.1.1 United States Inactivated Vaccines Market by Type
10.1.6.1.2 United States Inactivated Vaccines Market by Method
10.1.6.1.3 United States Inactivated Vaccines Market by Route of Administration
10.1.6.2 Canada Inactivated Vaccines Market
10.1.6.2.1 Canada Inactivated Vaccines Market by Type
10.1.6.2.2 Canada Inactivated Vaccines Market by Method
10.1.6.2.3 Canada Inactivated Vaccines Market by Route of Administration
10.1.6.3 Mexico Inactivated Vaccines Market
10.1.6.3.1 Mexico Inactivated Vaccines Market by Type
10.1.6.3.2 Mexico Inactivated Vaccines Market by Method
10.1.6.3.3 Mexico Inactivated Vaccines Market by Route of Administration
10.2. EUROPE
10.2.1 Europe Inactivated Vaccines Market Overview
10.2.2 Europe Inactivated Vaccines Market Forecasts and Analysis
10.2.3 Europe Inactivated Vaccines Market Forecasts and Analysis - By Type
10.2.4 Europe Inactivated Vaccines Market Forecasts and Analysis - By Method
10.2.5 Europe Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.2.6 Europe Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Inactivated Vaccines Market
10.2.6.1.1 Germany Inactivated Vaccines Market by Type
10.2.6.1.2 Germany Inactivated Vaccines Market by Method
10.2.6.1.3 Germany Inactivated Vaccines Market by Route of Administration
10.2.6.2 France Inactivated Vaccines Market
10.2.6.2.1 France Inactivated Vaccines Market by Type
10.2.6.2.2 France Inactivated Vaccines Market by Method
10.2.6.2.3 France Inactivated Vaccines Market by Route of Administration
10.2.6.3 Italy Inactivated Vaccines Market
10.2.6.3.1 Italy Inactivated Vaccines Market by Type
10.2.6.3.2 Italy Inactivated Vaccines Market by Method
10.2.6.3.3 Italy Inactivated Vaccines Market by Route of Administration
10.2.6.4 Spain Inactivated Vaccines Market
10.2.6.4.1 Spain Inactivated Vaccines Market by Type
10.2.6.4.2 Spain Inactivated Vaccines Market by Method
10.2.6.4.3 Spain Inactivated Vaccines Market by Route of Administration
10.2.6.5 United Kingdom Inactivated Vaccines Market
10.2.6.5.1 United Kingdom Inactivated Vaccines Market by Type
10.2.6.5.2 United Kingdom Inactivated Vaccines Market by Method
10.2.6.5.3 United Kingdom Inactivated Vaccines Market by Route of Administration
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Inactivated Vaccines Market Overview
10.3.2 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis - By Method
10.3.5 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.3.6 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Inactivated Vaccines Market
10.3.6.1.1 Australia Inactivated Vaccines Market by Type
10.3.6.1.2 Australia Inactivated Vaccines Market by Method
10.3.6.1.3 Australia Inactivated Vaccines Market by Route of Administration
10.3.6.2 China Inactivated Vaccines Market
10.3.6.2.1 China Inactivated Vaccines Market by Type
10.3.6.2.2 China Inactivated Vaccines Market by Method
10.3.6.2.3 China Inactivated Vaccines Market by Route of Administration
10.3.6.3 India Inactivated Vaccines Market
10.3.6.3.1 India Inactivated Vaccines Market by Type
10.3.6.3.2 India Inactivated Vaccines Market by Method
10.3.6.3.3 India Inactivated Vaccines Market by Route of Administration
10.3.6.4 Japan Inactivated Vaccines Market
10.3.6.4.1 Japan Inactivated Vaccines Market by Type
10.3.6.4.2 Japan Inactivated Vaccines Market by Method
10.3.6.4.3 Japan Inactivated Vaccines Market by Route of Administration
10.3.6.5 South Korea Inactivated Vaccines Market
10.3.6.5.1 South Korea Inactivated Vaccines Market by Type
10.3.6.5.2 South Korea Inactivated Vaccines Market by Method
10.3.6.5.3 South Korea Inactivated Vaccines Market by Route of Administration
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Inactivated Vaccines Market Overview
10.4.2 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis - By Method
10.4.5 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.4.6 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Inactivated Vaccines Market
10.4.6.1.1 South Africa Inactivated Vaccines Market by Type
10.4.6.1.2 South Africa Inactivated Vaccines Market by Method
10.4.6.1.3 South Africa Inactivated Vaccines Market by Route of Administration
10.4.6.2 Saudi Arabia Inactivated Vaccines Market
10.4.6.2.1 Saudi Arabia Inactivated Vaccines Market by Type
10.4.6.2.2 Saudi Arabia Inactivated Vaccines Market by Method
10.4.6.2.3 Saudi Arabia Inactivated Vaccines Market by Route of Administration
10.4.6.3 U.A.E Inactivated Vaccines Market
10.4.6.3.1 U.A.E Inactivated Vaccines Market by Type
10.4.6.3.2 U.A.E Inactivated Vaccines Market by Method
10.4.6.3.3 U.A.E Inactivated Vaccines Market by Route of Administration
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Inactivated Vaccines Market Overview
10.5.2 South and Central America Inactivated Vaccines Market Forecasts and Analysis
10.5.3 South and Central America Inactivated Vaccines Market Forecasts and Analysis - By Type
10.5.4 South and Central America Inactivated Vaccines Market Forecasts and Analysis - By Method
10.5.5 South and Central America Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.5.6 South and Central America Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Inactivated Vaccines Market
10.5.6.1.1 Brazil Inactivated Vaccines Market by Type
10.5.6.1.2 Brazil Inactivated Vaccines Market by Method
10.5.6.1.3 Brazil Inactivated Vaccines Market by Route of Administration
10.5.6.2 Argentina Inactivated Vaccines Market
10.5.6.2.1 Argentina Inactivated Vaccines Market by Type
10.5.6.2.2 Argentina Inactivated Vaccines Market by Method
10.5.6.2.3 Argentina Inactivated Vaccines Market by Route of Administration
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INACTIVATED VACCINES MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. INACTIVATED VACCINES MARKET, KEY COMPANY PROFILES
13.1. BHARAT BIOTECH
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CSL LTD.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. EMERGENT BIOSOLUTIONS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GLAXOSMITHKLINE PLC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MERCK AND CO., INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NOVARTIS AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PFIZER INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SANOFI
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SEQIRUS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. VALNEVA SE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Bharat Biotech
2. CSL Ltd.
3. Emergent BioSolutions
4. GlaxoSmithKline plc
5. Merck & Co., Inc.
6. Novartis AG
7. Pfizer Inc.
8. Sanofi
9. Seqirus
10. Valneva SE
1. Bharat Biotech
2. CSL Ltd.
3. Emergent BioSolutions
4. GlaxoSmithKline plc
5. Merck & Co., Inc.
6. Novartis AG
7. Pfizer Inc.
8. Sanofi
9. Seqirus
10. Valneva SE
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount